Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back

Prostate cancer is the most common cancer in men worldwide. To improve future drug development and patient management, surrogate biomarkers associated with relevant outcomes are required. Circulating tumour cells (CTCs) are tumour cells that can enter the circulatory system, and are principally resp...

Full description

Bibliographic Details
Main Authors:	Luis León-Mateos, María Vieito, Urbano Anido, Rafael López López, Laura Muinelo Romay
Format:	Article
Language:	English
Published:	MDPI AG 2016-09-01
Series:	International Journal of Molecular Sciences
Subjects:	prostate cancer circulating tumour cells tumour markers precision oncology
Online Access:	http://www.mdpi.com/1422-0067/17/9/1580

Similar Items

Biosensors for the Detection of Circulating Tumour Cells
by: Clotilde Costa, et al.
Published: (2014-03-01)

Three dimensional telomeric profiles in circulating tumour cells as a method of monitoring treatment response in high-risk prostate cancer patients
by: Wark, Landon, et al.
Published: (2016)

Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
by: Macías-García Laura, et al.
Published: (2012-10-01)

The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial
by: Gráinne Sheill, et al.
Published: (2017-10-01)

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
by: Ashleigh C. McEvoy, et al.
Published: (2018-07-01)

Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)
by: Brian Hayes, et al.
Published: (2021-09-01)

Neuroendocrine Tumour of the Prostate: A Rare Variant
by: Ozer Ural Cakici, et al.
Published: (2013-12-01)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
by: Laura Muinelo-Romay, et al.
Published: (2018-08-01)

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
by: Laura Muinelo-Romay, et al.
Published: (2014-01-01)

Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
by: Arutha Kulasinghe, et al.
Published: (2019-01-01)

NANOPARTICLES AS EMERGING DIAGNOSTIC TOOLS IN LIQUID TUMOURS
by: Ana Sofia Matias, et al.
Published: (2018-09-01)

Liquid Biopsy in Oral Cancer
by: Fatima Lousada-Fernandez, et al.
Published: (2018-06-01)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
by: Chelala, C., et al.
Published: (2022)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
by: Jinbo Song, et al.
Published: (2021-05-01)

Circulating Tumour Cells as Prognostic Biomarkers in Colorectal Cancer: A Systematic Review
by: Léa Veyrune, et al.
Published: (2021-04-01)

A Review of Circulating Tumour Cell Enrichment Technologies
by: Amelia J. Rushton, et al.
Published: (2021-02-01)

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
by: Karl Payne, et al.
Published: (2019-08-01)

Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study
by: Laura Marconato, et al.
Published: (2019-02-01)

Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
by: Stefano Guadagni, et al.
Published: (2020-03-01)

Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study
by: Ito Hiroaki, et al.
Published: (2012-08-01)

Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice
by: Simonetta Astigiano, et al.
Published: (2017-01-01)

HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
by: Cláudia Lopes, et al.
Published: (2021-09-01)

Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa
by: Daleen Geldenhuys, et al.
Published: (2020-10-01)

Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer
by: Lijuan Wang, et al.
Published: (2021-02-01)

Accuracy of Tumour-Associated Circulating Endothelial Cells as a Screening Biomarker for Clinically Significant Prostate Cancer
by: Sebastian Chakrit Bhakdi, et al.
Published: (2019-07-01)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
by: Ruth E Board, et al.
Published: (2007-01-01)

The challenges of detecting circulating tumour cells in sarcoma
by: Marta Tellez-Gabriel, et al.
Published: (2016-09-01)

Challenges and achievements of liquid biopsy technologies employed in early breast cancer
by: Alfonso Alba-Bernal, et al.
Published: (2020-12-01)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
by: Luis León-Mateos, et al.
Published: (2020-07-01)

Assessment of TRUS (with Colour Doppler) and MRI with TRUS Guided Biopsy in Prostatic Lesion Diagnosis – A Comparative Study
by: Mohammed Ahetasham, et al.
Published: (2019-07-01)

Rare Tumours of the Testis: Twelve Years of Experience
by: Zeynep Oruc, et al.
Published: (2020-10-01)

Recent Advances in Understanding the Role of Autophagy in Paediatric Brain Tumours
by: Francesca Gatto, et al.
Published: (2021-03-01)

Malignant tumours of the hand and wrist
by: Binu P Thomas, et al.
Published: (2011-01-01)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
by: Matthew Loft, et al.
Published: (2019-07-01)

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
by: Marta Tellez-Gabriel, et al.
Published: (2016-12-01)

A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer
by: Stefano Guadagni, et al.
Published: (2020-07-01)

Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
by: Vanathi Perumal, et al.
Published: (2019-03-01)

Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1
by: Yujun Tang, et al.
Published: (2019-11-01)

Molecular analysis of single circulating tumour cells following long‐term storage of clinical samples
by: Barbara Mesquita, et al.
Published: (2017-12-01)

Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles
by: Carlos Aya-Bonilla, et al.
Published: (2019-01-01)